KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 87 filers reported holding KRYSTAL BIOTECH INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,983,600 | +789.3% | 17,100 | +800.0% | 0.05% | +840.0% |
| Q2 2023 | $223,060 | -90.9% | 1,900 | -93.9% | 0.01% | -91.2% |
| Q4 2022 | $2,455,820 | +108.5% | 31,000 | +83.4% | 0.06% | +96.6% |
| Q3 2022 | $1,178,000 | -60.4% | 16,900 | -70.3% | 0.03% | -64.6% |
| Q3 2021 | $2,971,000 | +748.9% | 56,900 | +555.2% | 0.08% | +156.2% |
| Q2 2019 | $350,000 | +67.5% | 8,685 | -13.5% | 0.03% | +6.7% |
| Q4 2018 | $209,000 | – | 10,038 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |